Advertisement

Index by author

January 01, 2008; Volume 36,Issue 1

A

  1. Adjei, Araba A.

    1. Effect of Resveratrol on 17β-Estradiol Sulfation by Human Hepatic and Jejunal S9 and Recombinant Sulfotransferase 1E1
      Anna M. Furimsky, Carol E. Green, Lewanne E. Hunt Sharp, Paul Catz, Araba A. Adjei, Toufan Parman, Izet M. Kapetanovic, Richard M. Weinshilboum and Lalitha V. Iyer
      Drug Metabolism and Disposition January 2008, 36 (1) 129-136; DOI: https://doi.org/10.1124/dmd.107.016725

  2. Andersson, Tommy B.

    1. HepaRG Cells as an in Vitro Model for Evaluation of Cytochrome P450 Induction in Humans
      Kajsa P. Kanebratt and Tommy B. Andersson
      Drug Metabolism and Disposition January 2008, 36 (1) 137-145; DOI: https://doi.org/10.1124/dmd.107.017418

B

  1. Backman, Janne T.

    1. Trimethoprim and the CYP2C8*3 Allele Have Opposite Effects on the Pharmacokinetics of Pioglitazone
      Aleksi Tornio, Mikko Niemi, Pertti J. Neuvonen and Janne T. Backman
      Drug Metabolism and Disposition January 2008, 36 (1) 73-80; DOI: https://doi.org/10.1124/dmd.107.018010

  2. Bennett, J.

    1. Investigation of Regional Mechanisms Responsible for Poor Oral Absorption in Humans of a Modified Release Preparation of the α-Adrenoreceptor Antagonist, 4-Amino-6,7-dimethoxy-2-(5-methanesulfonamido-1,2,3,4 tetrahydroisoquinol-2-yl)-5-(2-pyridyl)quinazoline (UK-338,003): The Rational Use of ex Vivo Intestine to Predict in Vivo Absorption
      A. Collett, R. H. Stephens, M. D. Harwood, M. Humphrey, L. Dallman, J. Bennett, J. Davis, G. L. Carlson and G. Warhurst
      Drug Metabolism and Disposition January 2008, 36 (1) 87-94; DOI: https://doi.org/10.1124/dmd.107.016865

  3. Blough, David K.

    1. The Influence of CYP3A5 Expression on the Extent of Hepatic CYP3A Inhibition Is Substrate-Dependent: An in Vitro-in Vivo Evaluation
      Nina Isoherranen, Shana R. Ludington, Raymond C. Givens, Jatinder K. Lamba, Susan N. Pusek, E. Claire Dees, David K. Blough, Kazunori Iwanaga, Roy L. Hawke, Erin G. Schuetz, Paul B. Watkins, Kenneth E. Thummel and Mary F. Paine
      Drug Metabolism and Disposition January 2008, 36 (1) 146-154; DOI: https://doi.org/10.1124/dmd.107.018382

  4. Bonnardeaux, Alain

    1. Effects of Chronic Renal Failure on Liver Drug Transporters
      Judith Naud, Josée Michaud, Francois A. Leblond, Stéphane Lefrancois, Alain Bonnardeaux and Vincent Pichette
      Drug Metabolism and Disposition January 2008, 36 (1) 124-128; DOI: https://doi.org/10.1124/dmd.107.018192

  5. Bow, Daniel A. J.

    1. Localization of P-gp (Abcb1) and Mrp2 (Abcc2) in Freshly Isolated Rat Hepatocytes
      Daniel A. J. Bow, Jennifer L. Perry, David S. Miller, John B. Pritchard and Kim L. R. Brouwer
      Drug Metabolism and Disposition January 2008, 36 (1) 198-202; DOI: https://doi.org/10.1124/dmd.107.018200

  6. Bridges, Arlene S.

    1. Multidrug Resistance-Associated Protein 2 Is Primarily Responsible for the Biliary Excretion of Fexofenadine in Mice
      Xianbin Tian, Maciej J. Zamek-Gliszczynski, Jun Li, Arlene S. Bridges, Ken-ichi Nezasa, Nita J. Patel, Thomas J. Raub and Kim L. R. Brouwer
      Drug Metabolism and Disposition January 2008, 36 (1) 61-64; DOI: https://doi.org/10.1124/dmd.107.017319

  7. Brouwer, Kim L. R.

    1. Localization of P-gp (Abcb1) and Mrp2 (Abcc2) in Freshly Isolated Rat Hepatocytes
      Daniel A. J. Bow, Jennifer L. Perry, David S. Miller, John B. Pritchard and Kim L. R. Brouwer
      Drug Metabolism and Disposition January 2008, 36 (1) 198-202; DOI: https://doi.org/10.1124/dmd.107.018200
    2. Multidrug Resistance-Associated Protein 2 Is Primarily Responsible for the Biliary Excretion of Fexofenadine in Mice
      Xianbin Tian, Maciej J. Zamek-Gliszczynski, Jun Li, Arlene S. Bridges, Ken-ichi Nezasa, Nita J. Patel, Thomas J. Raub and Kim L. R. Brouwer
      Drug Metabolism and Disposition January 2008, 36 (1) 61-64; DOI: https://doi.org/10.1124/dmd.107.017319

C

  1. Carlson, G. L.

    1. Investigation of Regional Mechanisms Responsible for Poor Oral Absorption in Humans of a Modified Release Preparation of the α-Adrenoreceptor Antagonist, 4-Amino-6,7-dimethoxy-2-(5-methanesulfonamido-1,2,3,4 tetrahydroisoquinol-2-yl)-5-(2-pyridyl)quinazoline (UK-338,003): The Rational Use of ex Vivo Intestine to Predict in Vivo Absorption
      A. Collett, R. H. Stephens, M. D. Harwood, M. Humphrey, L. Dallman, J. Bennett, J. Davis, G. L. Carlson and G. Warhurst
      Drug Metabolism and Disposition January 2008, 36 (1) 87-94; DOI: https://doi.org/10.1124/dmd.107.016865

  2. Catz, Paul

    1. Effect of Resveratrol on 17β-Estradiol Sulfation by Human Hepatic and Jejunal S9 and Recombinant Sulfotransferase 1E1
      Anna M. Furimsky, Carol E. Green, Lewanne E. Hunt Sharp, Paul Catz, Araba A. Adjei, Toufan Parman, Izet M. Kapetanovic, Richard M. Weinshilboum and Lalitha V. Iyer
      Drug Metabolism and Disposition January 2008, 36 (1) 129-136; DOI: https://doi.org/10.1124/dmd.107.016725

  3. Chang, Shu Y.

    1. Disposition and Metabolism of [14C]Brasofensine in Rats, Monkeys, and Humans
      Mingshe Zhu, Daisy B. Whigan, Shu Y. Chang and Randy C. Dockens
      Drug Metabolism and Disposition January 2008, 36 (1) 24-35; DOI: https://doi.org/10.1124/dmd.107.016139

  4. Chen, Gang

    1. Regulation of CYP2A6 Protein Expression by Skatole, Indole, and Testicular Steroids in Primary Cultured Pig Hepatocytes
      Gang Chen, Rebecca-Ayme Cue, Kerstin Lundstrom, Jeffrey D. Wood and Olena Doran
      Drug Metabolism and Disposition January 2008, 36 (1) 56-60; DOI: https://doi.org/10.1124/dmd.107.017285

  5. Chinn, Leslie W.

    1. The Effects of ABCB1 3′-Untranslated Region Variants on mRNA Stability
      Jason M. Gow, Leslie W. Chinn and Deanna L. Kroetz
      Drug Metabolism and Disposition January 2008, 36 (1) 10-15; DOI: https://doi.org/10.1124/dmd.107.017087

  6. Chuang, Victor Tuan Giam

    1. Subdomain IIIA of Dog Albumin Contains a Binding Site Similar to Site II of Human Albumin
      Ken-ichi Kaneko, Hikaru Fukuda, Victor Tuan Giam Chuang, Keishi Yamasaki, Kohichi Kawahara, Hitoshi Nakayama, Ayaka Suenaga, Toru Maruyama and Masaki Otagiri
      Drug Metabolism and Disposition January 2008, 36 (1) 81-86; DOI: https://doi.org/10.1124/dmd.107.016873

  7. Clifford, Michael N.

    1. Transport and Metabolism of Ferulic Acid through the Colonic Epithelium
      Laure Poquet, Michael N. Clifford and Gary Williamson
      Drug Metabolism and Disposition January 2008, 36 (1) 190-197; DOI: https://doi.org/10.1124/dmd.107.017558

  8. Collett, A.

    1. Investigation of Regional Mechanisms Responsible for Poor Oral Absorption in Humans of a Modified Release Preparation of the α-Adrenoreceptor Antagonist, 4-Amino-6,7-dimethoxy-2-(5-methanesulfonamido-1,2,3,4 tetrahydroisoquinol-2-yl)-5-(2-pyridyl)quinazoline (UK-338,003): The Rational Use of ex Vivo Intestine to Predict in Vivo Absorption
      A. Collett, R. H. Stephens, M. D. Harwood, M. Humphrey, L. Dallman, J. Bennett, J. Davis, G. L. Carlson and G. Warhurst
      Drug Metabolism and Disposition January 2008, 36 (1) 87-94; DOI: https://doi.org/10.1124/dmd.107.016865

  9. Coquette, Alain

    1. Pharmacokinetics and Metabolism of 14C-Brivaracetam, a Novel SV2A Ligand, in Healthy Subjects
      Maria Laura Sargentini-Maier, Pascal Espié, Alain Coquette and Armel Stockis
      Drug Metabolism and Disposition January 2008, 36 (1) 36-45; DOI: https://doi.org/10.1124/dmd.107.017129

  10. Cue, Rebecca-Ayme

    1. Regulation of CYP2A6 Protein Expression by Skatole, Indole, and Testicular Steroids in Primary Cultured Pig Hepatocytes
      Gang Chen, Rebecca-Ayme Cue, Kerstin Lundstrom, Jeffrey D. Wood and Olena Doran
      Drug Metabolism and Disposition January 2008, 36 (1) 56-60; DOI: https://doi.org/10.1124/dmd.107.017285

D

  1. Dallman, L.

    1. Investigation of Regional Mechanisms Responsible for Poor Oral Absorption in Humans of a Modified Release Preparation of the α-Adrenoreceptor Antagonist, 4-Amino-6,7-dimethoxy-2-(5-methanesulfonamido-1,2,3,4 tetrahydroisoquinol-2-yl)-5-(2-pyridyl)quinazoline (UK-338,003): The Rational Use of ex Vivo Intestine to Predict in Vivo Absorption
      A. Collett, R. H. Stephens, M. D. Harwood, M. Humphrey, L. Dallman, J. Bennett, J. Davis, G. L. Carlson and G. Warhurst
      Drug Metabolism and Disposition January 2008, 36 (1) 87-94; DOI: https://doi.org/10.1124/dmd.107.016865

  2. Davis, J.

    1. Investigation of Regional Mechanisms Responsible for Poor Oral Absorption in Humans of a Modified Release Preparation of the α-Adrenoreceptor Antagonist, 4-Amino-6,7-dimethoxy-2-(5-methanesulfonamido-1,2,3,4 tetrahydroisoquinol-2-yl)-5-(2-pyridyl)quinazoline (UK-338,003): The Rational Use of ex Vivo Intestine to Predict in Vivo Absorption
      A. Collett, R. H. Stephens, M. D. Harwood, M. Humphrey, L. Dallman, J. Bennett, J. Davis, G. L. Carlson and G. Warhurst
      Drug Metabolism and Disposition January 2008, 36 (1) 87-94; DOI: https://doi.org/10.1124/dmd.107.016865

  3. Dees, E. Claire

    1. The Influence of CYP3A5 Expression on the Extent of Hepatic CYP3A Inhibition Is Substrate-Dependent: An in Vitro-in Vivo Evaluation
      Nina Isoherranen, Shana R. Ludington, Raymond C. Givens, Jatinder K. Lamba, Susan N. Pusek, E. Claire Dees, David K. Blough, Kazunori Iwanaga, Roy L. Hawke, Erin G. Schuetz, Paul B. Watkins, Kenneth E. Thummel and Mary F. Paine
      Drug Metabolism and Disposition January 2008, 36 (1) 146-154; DOI: https://doi.org/10.1124/dmd.107.018382

  4. Degawa, Masakuni

    1. Hepatic UDP-Glucuronosyltransferases Responsible for Glucuronidation of Thyroxine in Humans
      Yoshihisa Kato, Shin-ichi Ikushiro, Yoshikazu Emi, Sekihiro Tamaki, Hiroshi Suzuki, Toshiyuki Sakaki, Shizuo Yamada and Masakuni Degawa
      Drug Metabolism and Disposition January 2008, 36 (1) 51-55; DOI: https://doi.org/10.1124/dmd.107.018184

  5. Dockens, Randy C.

    1. Disposition and Metabolism of [14C]Brasofensine in Rats, Monkeys, and Humans
      Mingshe Zhu, Daisy B. Whigan, Shu Y. Chang and Randy C. Dockens
      Drug Metabolism and Disposition January 2008, 36 (1) 24-35; DOI: https://doi.org/10.1124/dmd.107.016139

  6. Doran, Olena

    1. Regulation of CYP2A6 Protein Expression by Skatole, Indole, and Testicular Steroids in Primary Cultured Pig Hepatocytes
      Gang Chen, Rebecca-Ayme Cue, Kerstin Lundstrom, Jeffrey D. Wood and Olena Doran
      Drug Metabolism and Disposition January 2008, 36 (1) 56-60; DOI: https://doi.org/10.1124/dmd.107.017285

  7. Dumas, Todd E.

    1. Pharmacokinetics and Metabolic Profile of Free, Conjugated, and Total Silymarin Flavonolignans in Human Plasma after Oral Administration of Milk Thistle Extract
      Zhiming Wen, Todd E. Dumas, Sarah J. Schrieber, Roy L. Hawke, Michael W. Fried and Philip C. Smith
      Drug Metabolism and Disposition January 2008, 36 (1) 65-72; DOI: https://doi.org/10.1124/dmd.107.017566

E

  1. Emi, Yoshikazu

    1. Hepatic UDP-Glucuronosyltransferases Responsible for Glucuronidation of Thyroxine in Humans
      Yoshihisa Kato, Shin-ichi Ikushiro, Yoshikazu Emi, Sekihiro Tamaki, Hiroshi Suzuki, Toshiyuki Sakaki, Shizuo Yamada and Masakuni Degawa
      Drug Metabolism and Disposition January 2008, 36 (1) 51-55; DOI: https://doi.org/10.1124/dmd.107.018184

  2. Espié, Pascal

    1. Pharmacokinetics and Metabolism of 14C-Brivaracetam, a Novel SV2A Ligand, in Healthy Subjects
      Maria Laura Sargentini-Maier, Pascal Espié, Alain Coquette and Armel Stockis
      Drug Metabolism and Disposition January 2008, 36 (1) 36-45; DOI: https://doi.org/10.1124/dmd.107.017129

  3. Evans, Allan M.

    1. Glucuronidation of Mycophenolic Acid by Wistar and Mrp2-Deficient TR- Rat Liver Microsomes
      Ian S. Westley, Raymond G. Morris, Allan M. Evans and Benedetta C. Sallustio
      Drug Metabolism and Disposition January 2008, 36 (1) 46-50; DOI: https://doi.org/10.1124/dmd.107.017210

F

  1. Fried, Michael W.

    1. Pharmacokinetics and Metabolic Profile of Free, Conjugated, and Total Silymarin Flavonolignans in Human Plasma after Oral Administration of Milk Thistle Extract
      Zhiming Wen, Todd E. Dumas, Sarah J. Schrieber, Roy L. Hawke, Michael W. Fried and Philip C. Smith
      Drug Metabolism and Disposition January 2008, 36 (1) 65-72; DOI: https://doi.org/10.1124/dmd.107.017566

  2. Fujita, Takuya

    1. Oseltamivir (Tamiflu) Efflux Transport at the Blood-Brain Barrier via P-Glycoprotein
      Kaori Morimoto, Masanori Nakakariya, Yoshiyuki Shirasaka, Chihaya Kakinuma, Takuya Fujita, Ikumi Tamai and Takuo Ogihara
      Drug Metabolism and Disposition January 2008, 36 (1) 6-9; DOI: https://doi.org/10.1124/dmd.107.017699

  3. Fukuda, Hikaru

    1. Subdomain IIIA of Dog Albumin Contains a Binding Site Similar to Site II of Human Albumin
      Ken-ichi Kaneko, Hikaru Fukuda, Victor Tuan Giam Chuang, Keishi Yamasaki, Kohichi Kawahara, Hitoshi Nakayama, Ayaka Suenaga, Toru Maruyama and Masaki Otagiri
      Drug Metabolism and Disposition January 2008, 36 (1) 81-86; DOI: https://doi.org/10.1124/dmd.107.016873

  4. Furimsky, Anna M.

    1. Effect of Resveratrol on 17β-Estradiol Sulfation by Human Hepatic and Jejunal S9 and Recombinant Sulfotransferase 1E1
      Anna M. Furimsky, Carol E. Green, Lewanne E. Hunt Sharp, Paul Catz, Araba A. Adjei, Toufan Parman, Izet M. Kapetanovic, Richard M. Weinshilboum and Lalitha V. Iyer
      Drug Metabolism and Disposition January 2008, 36 (1) 129-136; DOI: https://doi.org/10.1124/dmd.107.016725

G

  1. Ghose, Romi

    1. Regulation of Hepatic Drug-Metabolizing Enzyme Genes by Toll-Like Receptor 4 Signaling Is Independent of Toll-Interleukin 1 Receptor Domain-Containing Adaptor Protein
      Romi Ghose, Damara White, Tao Guo, Jesus Vallejo and Saul J. Karpen
      Drug Metabolism and Disposition January 2008, 36 (1) 95-101; DOI: https://doi.org/10.1124/dmd.107.018051

  2. Givens, Raymond C.

    1. The Influence of CYP3A5 Expression on the Extent of Hepatic CYP3A Inhibition Is Substrate-Dependent: An in Vitro-in Vivo Evaluation
      Nina Isoherranen, Shana R. Ludington, Raymond C. Givens, Jatinder K. Lamba, Susan N. Pusek, E. Claire Dees, David K. Blough, Kazunori Iwanaga, Roy L. Hawke, Erin G. Schuetz, Paul B. Watkins, Kenneth E. Thummel and Mary F. Paine
      Drug Metabolism and Disposition January 2008, 36 (1) 146-154; DOI: https://doi.org/10.1124/dmd.107.018382

  3. Gow, Jason M.

    1. The Effects of ABCB1 3′-Untranslated Region Variants on mRNA Stability
      Jason M. Gow, Leslie W. Chinn and Deanna L. Kroetz
      Drug Metabolism and Disposition January 2008, 36 (1) 10-15; DOI: https://doi.org/10.1124/dmd.107.017087

  4. Green, Carol E.

    1. Effect of Resveratrol on 17β-Estradiol Sulfation by Human Hepatic and Jejunal S9 and Recombinant Sulfotransferase 1E1
      Anna M. Furimsky, Carol E. Green, Lewanne E. Hunt Sharp, Paul Catz, Araba A. Adjei, Toufan Parman, Izet M. Kapetanovic, Richard M. Weinshilboum and Lalitha V. Iyer
      Drug Metabolism and Disposition January 2008, 36 (1) 129-136; DOI: https://doi.org/10.1124/dmd.107.016725

  5. Guo, Tao

    1. Regulation of Hepatic Drug-Metabolizing Enzyme Genes by Toll-Like Receptor 4 Signaling Is Independent of Toll-Interleukin 1 Receptor Domain-Containing Adaptor Protein
      Romi Ghose, Damara White, Tao Guo, Jesus Vallejo and Saul J. Karpen
      Drug Metabolism and Disposition January 2008, 36 (1) 95-101; DOI: https://doi.org/10.1124/dmd.107.018051

H

  1. Harwood, M. D.

    1. Investigation of Regional Mechanisms Responsible for Poor Oral Absorption in Humans of a Modified Release Preparation of the α-Adrenoreceptor Antagonist, 4-Amino-6,7-dimethoxy-2-(5-methanesulfonamido-1,2,3,4 tetrahydroisoquinol-2-yl)-5-(2-pyridyl)quinazoline (UK-338,003): The Rational Use of ex Vivo Intestine to Predict in Vivo Absorption
      A. Collett, R. H. Stephens, M. D. Harwood, M. Humphrey, L. Dallman, J. Bennett, J. Davis, G. L. Carlson and G. Warhurst
      Drug Metabolism and Disposition January 2008, 36 (1) 87-94; DOI: https://doi.org/10.1124/dmd.107.016865

  2. Hawke, Roy L.

    1. The Influence of CYP3A5 Expression on the Extent of Hepatic CYP3A Inhibition Is Substrate-Dependent: An in Vitro-in Vivo Evaluation
      Nina Isoherranen, Shana R. Ludington, Raymond C. Givens, Jatinder K. Lamba, Susan N. Pusek, E. Claire Dees, David K. Blough, Kazunori Iwanaga, Roy L. Hawke, Erin G. Schuetz, Paul B. Watkins, Kenneth E. Thummel and Mary F. Paine
      Drug Metabolism and Disposition January 2008, 36 (1) 146-154; DOI: https://doi.org/10.1124/dmd.107.018382
    2. Pharmacokinetics and Metabolic Profile of Free, Conjugated, and Total Silymarin Flavonolignans in Human Plasma after Oral Administration of Milk Thistle Extract
      Zhiming Wen, Todd E. Dumas, Sarah J. Schrieber, Roy L. Hawke, Michael W. Fried and Philip C. Smith
      Drug Metabolism and Disposition January 2008, 36 (1) 65-72; DOI: https://doi.org/10.1124/dmd.107.017566

  3. Humphrey, M.

    1. Investigation of Regional Mechanisms Responsible for Poor Oral Absorption in Humans of a Modified Release Preparation of the α-Adrenoreceptor Antagonist, 4-Amino-6,7-dimethoxy-2-(5-methanesulfonamido-1,2,3,4 tetrahydroisoquinol-2-yl)-5-(2-pyridyl)quinazoline (UK-338,003): The Rational Use of ex Vivo Intestine to Predict in Vivo Absorption
      A. Collett, R. H. Stephens, M. D. Harwood, M. Humphrey, L. Dallman, J. Bennett, J. Davis, G. L. Carlson and G. Warhurst
      Drug Metabolism and Disposition January 2008, 36 (1) 87-94; DOI: https://doi.org/10.1124/dmd.107.016865

I

  1. Ikushiro, Shin-ichi

    1. Hepatic UDP-Glucuronosyltransferases Responsible for Glucuronidation of Thyroxine in Humans
      Yoshihisa Kato, Shin-ichi Ikushiro, Yoshikazu Emi, Sekihiro Tamaki, Hiroshi Suzuki, Toshiyuki Sakaki, Shizuo Yamada and Masakuni Degawa
      Drug Metabolism and Disposition January 2008, 36 (1) 51-55; DOI: https://doi.org/10.1124/dmd.107.018184

  2. Isoherranen, Nina

    1. The Influence of CYP3A5 Expression on the Extent of Hepatic CYP3A Inhibition Is Substrate-Dependent: An in Vitro-in Vivo Evaluation
      Nina Isoherranen, Shana R. Ludington, Raymond C. Givens, Jatinder K. Lamba, Susan N. Pusek, E. Claire Dees, David K. Blough, Kazunori Iwanaga, Roy L. Hawke, Erin G. Schuetz, Paul B. Watkins, Kenneth E. Thummel and Mary F. Paine
      Drug Metabolism and Disposition January 2008, 36 (1) 146-154; DOI: https://doi.org/10.1124/dmd.107.018382

  3. Iwanaga, Kazunori

    1. The Influence of CYP3A5 Expression on the Extent of Hepatic CYP3A Inhibition Is Substrate-Dependent: An in Vitro-in Vivo Evaluation
      Nina Isoherranen, Shana R. Ludington, Raymond C. Givens, Jatinder K. Lamba, Susan N. Pusek, E. Claire Dees, David K. Blough, Kazunori Iwanaga, Roy L. Hawke, Erin G. Schuetz, Paul B. Watkins, Kenneth E. Thummel and Mary F. Paine
      Drug Metabolism and Disposition January 2008, 36 (1) 146-154; DOI: https://doi.org/10.1124/dmd.107.018382

  4. Iyer, Lalitha V.

    1. Effect of Resveratrol on 17β-Estradiol Sulfation by Human Hepatic and Jejunal S9 and Recombinant Sulfotransferase 1E1
      Anna M. Furimsky, Carol E. Green, Lewanne E. Hunt Sharp, Paul Catz, Araba A. Adjei, Toufan Parman, Izet M. Kapetanovic, Richard M. Weinshilboum and Lalitha V. Iyer
      Drug Metabolism and Disposition January 2008, 36 (1) 129-136; DOI: https://doi.org/10.1124/dmd.107.016725

J

  1. Jeannesson, Elise

    1. Transcription Factor and Drug-Metabolizing Enzyme Gene Expression in Lymphocytes from Healthy Human Subjects
      Gérard Siest, Elise Jeannesson, Jean-Brice Marteau, Anastasia Samara, Bérangère Marie, Michèle Pfister and Sophie Visvikis-Siest
      Drug Metabolism and Disposition January 2008, 36 (1) 182-189; DOI: https://doi.org/10.1124/dmd.107.017228

K

  1. Kakinuma, Chihaya

    1. Oseltamivir (Tamiflu) Efflux Transport at the Blood-Brain Barrier via P-Glycoprotein
      Kaori Morimoto, Masanori Nakakariya, Yoshiyuki Shirasaka, Chihaya Kakinuma, Takuya Fujita, Ikumi Tamai and Takuo Ogihara
      Drug Metabolism and Disposition January 2008, 36 (1) 6-9; DOI: https://doi.org/10.1124/dmd.107.017699

  2. Kanebratt, Kajsa P.

    1. HepaRG Cells as an in Vitro Model for Evaluation of Cytochrome P450 Induction in Humans
      Kajsa P. Kanebratt and Tommy B. Andersson
      Drug Metabolism and Disposition January 2008, 36 (1) 137-145; DOI: https://doi.org/10.1124/dmd.107.017418

  3. Kaneko, Ken-ichi

    1. Subdomain IIIA of Dog Albumin Contains a Binding Site Similar to Site II of Human Albumin
      Ken-ichi Kaneko, Hikaru Fukuda, Victor Tuan Giam Chuang, Keishi Yamasaki, Kohichi Kawahara, Hitoshi Nakayama, Ayaka Suenaga, Toru Maruyama and Masaki Otagiri
      Drug Metabolism and Disposition January 2008, 36 (1) 81-86; DOI: https://doi.org/10.1124/dmd.107.016873

  4. Kapetanovic, Izet M.

    1. Effect of Resveratrol on 17β-Estradiol Sulfation by Human Hepatic and Jejunal S9 and Recombinant Sulfotransferase 1E1
      Anna M. Furimsky, Carol E. Green, Lewanne E. Hunt Sharp, Paul Catz, Araba A. Adjei, Toufan Parman, Izet M. Kapetanovic, Richard M. Weinshilboum and Lalitha V. Iyer
      Drug Metabolism and Disposition January 2008, 36 (1) 129-136; DOI: https://doi.org/10.1124/dmd.107.016725

  5. Karpen, Saul J.

    1. Regulation of Hepatic Drug-Metabolizing Enzyme Genes by Toll-Like Receptor 4 Signaling Is Independent of Toll-Interleukin 1 Receptor Domain-Containing Adaptor Protein
      Romi Ghose, Damara White, Tao Guo, Jesus Vallejo and Saul J. Karpen
      Drug Metabolism and Disposition January 2008, 36 (1) 95-101; DOI: https://doi.org/10.1124/dmd.107.018051

  6. Kartha, Jaya S.

    1. Mechanism-Based Inactivation of Lung-Selective Cytochrome P450 CYP2F Enzymes
      Jaya S. Kartha and Garold S. Yost
      Drug Metabolism and Disposition January 2008, 36 (1) 155-162; DOI: https://doi.org/10.1124/dmd.107.017897

  7. Kato, Yoshihisa

    1. Hepatic UDP-Glucuronosyltransferases Responsible for Glucuronidation of Thyroxine in Humans
      Yoshihisa Kato, Shin-ichi Ikushiro, Yoshikazu Emi, Sekihiro Tamaki, Hiroshi Suzuki, Toshiyuki Sakaki, Shizuo Yamada and Masakuni Degawa
      Drug Metabolism and Disposition January 2008, 36 (1) 51-55; DOI: https://doi.org/10.1124/dmd.107.018184

  8. Kawahara, Kohichi

    1. Subdomain IIIA of Dog Albumin Contains a Binding Site Similar to Site II of Human Albumin
      Ken-ichi Kaneko, Hikaru Fukuda, Victor Tuan Giam Chuang, Keishi Yamasaki, Kohichi Kawahara, Hitoshi Nakayama, Ayaka Suenaga, Toru Maruyama and Masaki Otagiri
      Drug Metabolism and Disposition January 2008, 36 (1) 81-86; DOI: https://doi.org/10.1124/dmd.107.016873

  9. Klaassen, Curtis

    1. Gender Differences in mRNA Expression of ATP-Binding Cassette Efflux and Bile Acid Transporters in Kidney, Liver, and Intestine of 5/6 Nephrectomized Rats
      Hong Lu and Curtis Klaassen
      Drug Metabolism and Disposition January 2008, 36 (1) 16-23; DOI: https://doi.org/10.1124/dmd.107.014845

  10. Kroetz, Deanna L.

    1. The Effects of ABCB1 3′-Untranslated Region Variants on mRNA Stability
      Jason M. Gow, Leslie W. Chinn and Deanna L. Kroetz
      Drug Metabolism and Disposition January 2008, 36 (1) 10-15; DOI: https://doi.org/10.1124/dmd.107.017087

L

  1. Lamba, Jatinder

    1. Novel Single Nucleotide Polymorphisms in the Promoter and Intron 1 of Human Pregnane X Receptor/NR1I2 and Their Association with CYP3A4 Expression
      Jatinder Lamba, Vishal Lamba, Stephen Strom, Raman Venkataramanan and Erin Schuetz
      Drug Metabolism and Disposition January 2008, 36 (1) 169-181; DOI: https://doi.org/10.1124/dmd.107.016600

  2. Lamba, Jatinder K.

    1. The Influence of CYP3A5 Expression on the Extent of Hepatic CYP3A Inhibition Is Substrate-Dependent: An in Vitro-in Vivo Evaluation
      Nina Isoherranen, Shana R. Ludington, Raymond C. Givens, Jatinder K. Lamba, Susan N. Pusek, E. Claire Dees, David K. Blough, Kazunori Iwanaga, Roy L. Hawke, Erin G. Schuetz, Paul B. Watkins, Kenneth E. Thummel and Mary F. Paine
      Drug Metabolism and Disposition January 2008, 36 (1) 146-154; DOI: https://doi.org/10.1124/dmd.107.018382

  3. Lamba, Vishal

    1. Novel Single Nucleotide Polymorphisms in the Promoter and Intron 1 of Human Pregnane X Receptor/NR1I2 and Their Association with CYP3A4 Expression
      Jatinder Lamba, Vishal Lamba, Stephen Strom, Raman Venkataramanan and Erin Schuetz
      Drug Metabolism and Disposition January 2008, 36 (1) 169-181; DOI: https://doi.org/10.1124/dmd.107.016600

  4. Leblond, Francois A.

    1. Effects of Chronic Renal Failure on Liver Drug Transporters
      Judith Naud, Josée Michaud, Francois A. Leblond, Stéphane Lefrancois, Alain Bonnardeaux and Vincent Pichette
      Drug Metabolism and Disposition January 2008, 36 (1) 124-128; DOI: https://doi.org/10.1124/dmd.107.018192

  5. Lefrancois, Stéphane

    1. Effects of Chronic Renal Failure on Liver Drug Transporters
      Judith Naud, Josée Michaud, Francois A. Leblond, Stéphane Lefrancois, Alain Bonnardeaux and Vincent Pichette
      Drug Metabolism and Disposition January 2008, 36 (1) 124-128; DOI: https://doi.org/10.1124/dmd.107.018192

  6. Li, Jun

    1. Multidrug Resistance-Associated Protein 2 Is Primarily Responsible for the Biliary Excretion of Fexofenadine in Mice
      Xianbin Tian, Maciej J. Zamek-Gliszczynski, Jun Li, Arlene S. Bridges, Ken-ichi Nezasa, Nita J. Patel, Thomas J. Raub and Kim L. R. Brouwer
      Drug Metabolism and Disposition January 2008, 36 (1) 61-64; DOI: https://doi.org/10.1124/dmd.107.017319

  7. Lu, Hong

    1. Gender Differences in mRNA Expression of ATP-Binding Cassette Efflux and Bile Acid Transporters in Kidney, Liver, and Intestine of 5/6 Nephrectomized Rats
      Hong Lu and Curtis Klaassen
      Drug Metabolism and Disposition January 2008, 36 (1) 16-23; DOI: https://doi.org/10.1124/dmd.107.014845

  8. Ludington, Shana R.

    1. The Influence of CYP3A5 Expression on the Extent of Hepatic CYP3A Inhibition Is Substrate-Dependent: An in Vitro-in Vivo Evaluation
      Nina Isoherranen, Shana R. Ludington, Raymond C. Givens, Jatinder K. Lamba, Susan N. Pusek, E. Claire Dees, David K. Blough, Kazunori Iwanaga, Roy L. Hawke, Erin G. Schuetz, Paul B. Watkins, Kenneth E. Thummel and Mary F. Paine
      Drug Metabolism and Disposition January 2008, 36 (1) 146-154; DOI: https://doi.org/10.1124/dmd.107.018382

  9. Lundstrom, Kerstin

    1. Regulation of CYP2A6 Protein Expression by Skatole, Indole, and Testicular Steroids in Primary Cultured Pig Hepatocytes
      Gang Chen, Rebecca-Ayme Cue, Kerstin Lundstrom, Jeffrey D. Wood and Olena Doran
      Drug Metabolism and Disposition January 2008, 36 (1) 56-60; DOI: https://doi.org/10.1124/dmd.107.017285

M

  1. Marie, Bérangère

    1. Transcription Factor and Drug-Metabolizing Enzyme Gene Expression in Lymphocytes from Healthy Human Subjects
      Gérard Siest, Elise Jeannesson, Jean-Brice Marteau, Anastasia Samara, Bérangère Marie, Michèle Pfister and Sophie Visvikis-Siest
      Drug Metabolism and Disposition January 2008, 36 (1) 182-189; DOI: https://doi.org/10.1124/dmd.107.017228

  2. Marteau, Jean-Brice

    1. Transcription Factor and Drug-Metabolizing Enzyme Gene Expression in Lymphocytes from Healthy Human Subjects
      Gérard Siest, Elise Jeannesson, Jean-Brice Marteau, Anastasia Samara, Bérangère Marie, Michèle Pfister and Sophie Visvikis-Siest
      Drug Metabolism and Disposition January 2008, 36 (1) 182-189; DOI: https://doi.org/10.1124/dmd.107.017228

  3. Maruyama, Toru

    1. Subdomain IIIA of Dog Albumin Contains a Binding Site Similar to Site II of Human Albumin
      Ken-ichi Kaneko, Hikaru Fukuda, Victor Tuan Giam Chuang, Keishi Yamasaki, Kohichi Kawahara, Hitoshi Nakayama, Ayaka Suenaga, Toru Maruyama and Masaki Otagiri
      Drug Metabolism and Disposition January 2008, 36 (1) 81-86; DOI: https://doi.org/10.1124/dmd.107.016873

  4. Maurer, Hans H.

    1. Identification of Cytochrome P450 Enzymes Involved in the Metabolism of the New Designer Drug 4′-Methyl-α-pyrrolidinobutyrophenone
      Frank T. Peters, Markus R. Meyer, Denis S. Theobald and Hans H. Maurer
      Drug Metabolism and Disposition January 2008, 36 (1) 163-168; DOI: https://doi.org/10.1124/dmd.107.017293

  5. Meyer, Markus R.

    1. Identification of Cytochrome P450 Enzymes Involved in the Metabolism of the New Designer Drug 4′-Methyl-α-pyrrolidinobutyrophenone
      Frank T. Peters, Markus R. Meyer, Denis S. Theobald and Hans H. Maurer
      Drug Metabolism and Disposition January 2008, 36 (1) 163-168; DOI: https://doi.org/10.1124/dmd.107.017293

  6. Michaud, Josée

    1. Effects of Chronic Renal Failure on Liver Drug Transporters
      Judith Naud, Josée Michaud, Francois A. Leblond, Stéphane Lefrancois, Alain Bonnardeaux and Vincent Pichette
      Drug Metabolism and Disposition January 2008, 36 (1) 124-128; DOI: https://doi.org/10.1124/dmd.107.018192

  7. Miller, David S.

    1. Localization of P-gp (Abcb1) and Mrp2 (Abcc2) in Freshly Isolated Rat Hepatocytes
      Daniel A. J. Bow, Jennifer L. Perry, David S. Miller, John B. Pritchard and Kim L. R. Brouwer
      Drug Metabolism and Disposition January 2008, 36 (1) 198-202; DOI: https://doi.org/10.1124/dmd.107.018200

  8. Morimoto, Kaori

    1. Oseltamivir (Tamiflu) Efflux Transport at the Blood-Brain Barrier via P-Glycoprotein
      Kaori Morimoto, Masanori Nakakariya, Yoshiyuki Shirasaka, Chihaya Kakinuma, Takuya Fujita, Ikumi Tamai and Takuo Ogihara
      Drug Metabolism and Disposition January 2008, 36 (1) 6-9; DOI: https://doi.org/10.1124/dmd.107.017699

  9. Morris, Raymond G.

    1. Glucuronidation of Mycophenolic Acid by Wistar and Mrp2-Deficient TR- Rat Liver Microsomes
      Ian S. Westley, Raymond G. Morris, Allan M. Evans and Benedetta C. Sallustio
      Drug Metabolism and Disposition January 2008, 36 (1) 46-50; DOI: https://doi.org/10.1124/dmd.107.017210

  10. Murphy, Patrick J.

    1. The Development of Drug Metabolism Research as Expressed in the Publications of ASPET: Part 1, 1909–1958
      Patrick J. Murphy
      Drug Metabolism and Disposition January 2008, 36 (1) 1-5; DOI: https://doi.org/10.1124/dmd.107.017079

N

  1. Nakakariya, Masanori

    1. Oseltamivir (Tamiflu) Efflux Transport at the Blood-Brain Barrier via P-Glycoprotein
      Kaori Morimoto, Masanori Nakakariya, Yoshiyuki Shirasaka, Chihaya Kakinuma, Takuya Fujita, Ikumi Tamai and Takuo Ogihara
      Drug Metabolism and Disposition January 2008, 36 (1) 6-9; DOI: https://doi.org/10.1124/dmd.107.017699

  2. Nakayama, Hitoshi

    1. Subdomain IIIA of Dog Albumin Contains a Binding Site Similar to Site II of Human Albumin
      Ken-ichi Kaneko, Hikaru Fukuda, Victor Tuan Giam Chuang, Keishi Yamasaki, Kohichi Kawahara, Hitoshi Nakayama, Ayaka Suenaga, Toru Maruyama and Masaki Otagiri
      Drug Metabolism and Disposition January 2008, 36 (1) 81-86; DOI: https://doi.org/10.1124/dmd.107.016873

  3. Naud, Judith

    1. Effects of Chronic Renal Failure on Liver Drug Transporters
      Judith Naud, Josée Michaud, Francois A. Leblond, Stéphane Lefrancois, Alain Bonnardeaux and Vincent Pichette
      Drug Metabolism and Disposition January 2008, 36 (1) 124-128; DOI: https://doi.org/10.1124/dmd.107.018192

  4. Neuvonen, Pertti J.

    1. Trimethoprim and the CYP2C8*3 Allele Have Opposite Effects on the Pharmacokinetics of Pioglitazone
      Aleksi Tornio, Mikko Niemi, Pertti J. Neuvonen and Janne T. Backman
      Drug Metabolism and Disposition January 2008, 36 (1) 73-80; DOI: https://doi.org/10.1124/dmd.107.018010

  5. Nezasa, Ken-ichi

    1. Multidrug Resistance-Associated Protein 2 Is Primarily Responsible for the Biliary Excretion of Fexofenadine in Mice
      Xianbin Tian, Maciej J. Zamek-Gliszczynski, Jun Li, Arlene S. Bridges, Ken-ichi Nezasa, Nita J. Patel, Thomas J. Raub and Kim L. R. Brouwer
      Drug Metabolism and Disposition January 2008, 36 (1) 61-64; DOI: https://doi.org/10.1124/dmd.107.017319

  6. Niemi, Mikko

    1. Trimethoprim and the CYP2C8*3 Allele Have Opposite Effects on the Pharmacokinetics of Pioglitazone
      Aleksi Tornio, Mikko Niemi, Pertti J. Neuvonen and Janne T. Backman
      Drug Metabolism and Disposition January 2008, 36 (1) 73-80; DOI: https://doi.org/10.1124/dmd.107.018010

O

  1. Ogihara, Takuo

    1. Oseltamivir (Tamiflu) Efflux Transport at the Blood-Brain Barrier via P-Glycoprotein
      Kaori Morimoto, Masanori Nakakariya, Yoshiyuki Shirasaka, Chihaya Kakinuma, Takuya Fujita, Ikumi Tamai and Takuo Ogihara
      Drug Metabolism and Disposition January 2008, 36 (1) 6-9; DOI: https://doi.org/10.1124/dmd.107.017699

  2. Otagiri, Masaki

    1. Subdomain IIIA of Dog Albumin Contains a Binding Site Similar to Site II of Human Albumin
      Ken-ichi Kaneko, Hikaru Fukuda, Victor Tuan Giam Chuang, Keishi Yamasaki, Kohichi Kawahara, Hitoshi Nakayama, Ayaka Suenaga, Toru Maruyama and Masaki Otagiri
      Drug Metabolism and Disposition January 2008, 36 (1) 81-86; DOI: https://doi.org/10.1124/dmd.107.016873

P

  1. Paine, Mary F.

    1. The Influence of CYP3A5 Expression on the Extent of Hepatic CYP3A Inhibition Is Substrate-Dependent: An in Vitro-in Vivo Evaluation
      Nina Isoherranen, Shana R. Ludington, Raymond C. Givens, Jatinder K. Lamba, Susan N. Pusek, E. Claire Dees, David K. Blough, Kazunori Iwanaga, Roy L. Hawke, Erin G. Schuetz, Paul B. Watkins, Kenneth E. Thummel and Mary F. Paine
      Drug Metabolism and Disposition January 2008, 36 (1) 146-154; DOI: https://doi.org/10.1124/dmd.107.018382

  2. Pang, K. Sandy

    1. Permeability, Transport, and Metabolism of Solutes in Caco-2 Cell Monolayers: A Theoretical Study
      Huadong Sun and K. Sandy Pang
      Drug Metabolism and Disposition January 2008, 36 (1) 102-123; DOI: https://doi.org/10.1124/dmd.107.015321

  3. Parman, Toufan

    1. Effect of Resveratrol on 17β-Estradiol Sulfation by Human Hepatic and Jejunal S9 and Recombinant Sulfotransferase 1E1
      Anna M. Furimsky, Carol E. Green, Lewanne E. Hunt Sharp, Paul Catz, Araba A. Adjei, Toufan Parman, Izet M. Kapetanovic, Richard M. Weinshilboum and Lalitha V. Iyer
      Drug Metabolism and Disposition January 2008, 36 (1) 129-136; DOI: https://doi.org/10.1124/dmd.107.016725

  4. Patel, Nita J.

    1. Multidrug Resistance-Associated Protein 2 Is Primarily Responsible for the Biliary Excretion of Fexofenadine in Mice
      Xianbin Tian, Maciej J. Zamek-Gliszczynski, Jun Li, Arlene S. Bridges, Ken-ichi Nezasa, Nita J. Patel, Thomas J. Raub and Kim L. R. Brouwer
      Drug Metabolism and Disposition January 2008, 36 (1) 61-64; DOI: https://doi.org/10.1124/dmd.107.017319

  5. Perry, Jennifer L.

    1. Localization of P-gp (Abcb1) and Mrp2 (Abcc2) in Freshly Isolated Rat Hepatocytes
      Daniel A. J. Bow, Jennifer L. Perry, David S. Miller, John B. Pritchard and Kim L. R. Brouwer
      Drug Metabolism and Disposition January 2008, 36 (1) 198-202; DOI: https://doi.org/10.1124/dmd.107.018200

  6. Peters, Frank T.

    1. Identification of Cytochrome P450 Enzymes Involved in the Metabolism of the New Designer Drug 4′-Methyl-α-pyrrolidinobutyrophenone
      Frank T. Peters, Markus R. Meyer, Denis S. Theobald and Hans H. Maurer
      Drug Metabolism and Disposition January 2008, 36 (1) 163-168; DOI: https://doi.org/10.1124/dmd.107.017293

  7. Pfister, Michèle

    1. Transcription Factor and Drug-Metabolizing Enzyme Gene Expression in Lymphocytes from Healthy Human Subjects
      Gérard Siest, Elise Jeannesson, Jean-Brice Marteau, Anastasia Samara, Bérangère Marie, Michèle Pfister and Sophie Visvikis-Siest
      Drug Metabolism and Disposition January 2008, 36 (1) 182-189; DOI: https://doi.org/10.1124/dmd.107.017228

  8. Pichette, Vincent

    1. Effects of Chronic Renal Failure on Liver Drug Transporters
      Judith Naud, Josée Michaud, Francois A. Leblond, Stéphane Lefrancois, Alain Bonnardeaux and Vincent Pichette
      Drug Metabolism and Disposition January 2008, 36 (1) 124-128; DOI: https://doi.org/10.1124/dmd.107.018192

  9. Poquet, Laure

    1. Transport and Metabolism of Ferulic Acid through the Colonic Epithelium
      Laure Poquet, Michael N. Clifford and Gary Williamson
      Drug Metabolism and Disposition January 2008, 36 (1) 190-197; DOI: https://doi.org/10.1124/dmd.107.017558

  10. Pritchard, John B.

    1. Localization of P-gp (Abcb1) and Mrp2 (Abcc2) in Freshly Isolated Rat Hepatocytes
      Daniel A. J. Bow, Jennifer L. Perry, David S. Miller, John B. Pritchard and Kim L. R. Brouwer
      Drug Metabolism and Disposition January 2008, 36 (1) 198-202; DOI: https://doi.org/10.1124/dmd.107.018200

  11. Pusek, Susan N.

    1. The Influence of CYP3A5 Expression on the Extent of Hepatic CYP3A Inhibition Is Substrate-Dependent: An in Vitro-in Vivo Evaluation
      Nina Isoherranen, Shana R. Ludington, Raymond C. Givens, Jatinder K. Lamba, Susan N. Pusek, E. Claire Dees, David K. Blough, Kazunori Iwanaga, Roy L. Hawke, Erin G. Schuetz, Paul B. Watkins, Kenneth E. Thummel and Mary F. Paine
      Drug Metabolism and Disposition January 2008, 36 (1) 146-154; DOI: https://doi.org/10.1124/dmd.107.018382

R

  1. Raub, Thomas J.

    1. Multidrug Resistance-Associated Protein 2 Is Primarily Responsible for the Biliary Excretion of Fexofenadine in Mice
      Xianbin Tian, Maciej J. Zamek-Gliszczynski, Jun Li, Arlene S. Bridges, Ken-ichi Nezasa, Nita J. Patel, Thomas J. Raub and Kim L. R. Brouwer
      Drug Metabolism and Disposition January 2008, 36 (1) 61-64; DOI: https://doi.org/10.1124/dmd.107.017319

S

  1. Sakaki, Toshiyuki

    1. Hepatic UDP-Glucuronosyltransferases Responsible for Glucuronidation of Thyroxine in Humans
      Yoshihisa Kato, Shin-ichi Ikushiro, Yoshikazu Emi, Sekihiro Tamaki, Hiroshi Suzuki, Toshiyuki Sakaki, Shizuo Yamada and Masakuni Degawa
      Drug Metabolism and Disposition January 2008, 36 (1) 51-55; DOI: https://doi.org/10.1124/dmd.107.018184

  2. Sallustio, Benedetta C.

    1. Glucuronidation of Mycophenolic Acid by Wistar and Mrp2-Deficient TR- Rat Liver Microsomes
      Ian S. Westley, Raymond G. Morris, Allan M. Evans and Benedetta C. Sallustio
      Drug Metabolism and Disposition January 2008, 36 (1) 46-50; DOI: https://doi.org/10.1124/dmd.107.017210

  3. Samara, Anastasia

    1. Transcription Factor and Drug-Metabolizing Enzyme Gene Expression in Lymphocytes from Healthy Human Subjects
      Gérard Siest, Elise Jeannesson, Jean-Brice Marteau, Anastasia Samara, Bérangère Marie, Michèle Pfister and Sophie Visvikis-Siest
      Drug Metabolism and Disposition January 2008, 36 (1) 182-189; DOI: https://doi.org/10.1124/dmd.107.017228

  4. Sargentini-Maier, Maria Laura

    1. Pharmacokinetics and Metabolism of 14C-Brivaracetam, a Novel SV2A Ligand, in Healthy Subjects
      Maria Laura Sargentini-Maier, Pascal Espié, Alain Coquette and Armel Stockis
      Drug Metabolism and Disposition January 2008, 36 (1) 36-45; DOI: https://doi.org/10.1124/dmd.107.017129

  5. Schrieber, Sarah J.

    1. Pharmacokinetics and Metabolic Profile of Free, Conjugated, and Total Silymarin Flavonolignans in Human Plasma after Oral Administration of Milk Thistle Extract
      Zhiming Wen, Todd E. Dumas, Sarah J. Schrieber, Roy L. Hawke, Michael W. Fried and Philip C. Smith
      Drug Metabolism and Disposition January 2008, 36 (1) 65-72; DOI: https://doi.org/10.1124/dmd.107.017566

  6. Schuetz, Erin

    1. Novel Single Nucleotide Polymorphisms in the Promoter and Intron 1 of Human Pregnane X Receptor/NR1I2 and Their Association with CYP3A4 Expression
      Jatinder Lamba, Vishal Lamba, Stephen Strom, Raman Venkataramanan and Erin Schuetz
      Drug Metabolism and Disposition January 2008, 36 (1) 169-181; DOI: https://doi.org/10.1124/dmd.107.016600

  7. Schuetz, Erin G.

    1. The Influence of CYP3A5 Expression on the Extent of Hepatic CYP3A Inhibition Is Substrate-Dependent: An in Vitro-in Vivo Evaluation
      Nina Isoherranen, Shana R. Ludington, Raymond C. Givens, Jatinder K. Lamba, Susan N. Pusek, E. Claire Dees, David K. Blough, Kazunori Iwanaga, Roy L. Hawke, Erin G. Schuetz, Paul B. Watkins, Kenneth E. Thummel and Mary F. Paine
      Drug Metabolism and Disposition January 2008, 36 (1) 146-154; DOI: https://doi.org/10.1124/dmd.107.018382

  8. Sharp, Lewanne E. Hunt

    1. Effect of Resveratrol on 17β-Estradiol Sulfation by Human Hepatic and Jejunal S9 and Recombinant Sulfotransferase 1E1
      Anna M. Furimsky, Carol E. Green, Lewanne E. Hunt Sharp, Paul Catz, Araba A. Adjei, Toufan Parman, Izet M. Kapetanovic, Richard M. Weinshilboum and Lalitha V. Iyer
      Drug Metabolism and Disposition January 2008, 36 (1) 129-136; DOI: https://doi.org/10.1124/dmd.107.016725

  9. Shirasaka, Yoshiyuki

    1. Oseltamivir (Tamiflu) Efflux Transport at the Blood-Brain Barrier via P-Glycoprotein
      Kaori Morimoto, Masanori Nakakariya, Yoshiyuki Shirasaka, Chihaya Kakinuma, Takuya Fujita, Ikumi Tamai and Takuo Ogihara
      Drug Metabolism and Disposition January 2008, 36 (1) 6-9; DOI: https://doi.org/10.1124/dmd.107.017699

  10. Siest, Gérard

    1. Transcription Factor and Drug-Metabolizing Enzyme Gene Expression in Lymphocytes from Healthy Human Subjects
      Gérard Siest, Elise Jeannesson, Jean-Brice Marteau, Anastasia Samara, Bérangère Marie, Michèle Pfister and Sophie Visvikis-Siest
      Drug Metabolism and Disposition January 2008, 36 (1) 182-189; DOI: https://doi.org/10.1124/dmd.107.017228

  11. Smith, Philip C.

    1. Pharmacokinetics and Metabolic Profile of Free, Conjugated, and Total Silymarin Flavonolignans in Human Plasma after Oral Administration of Milk Thistle Extract
      Zhiming Wen, Todd E. Dumas, Sarah J. Schrieber, Roy L. Hawke, Michael W. Fried and Philip C. Smith
      Drug Metabolism and Disposition January 2008, 36 (1) 65-72; DOI: https://doi.org/10.1124/dmd.107.017566

  12. Stephens, R. H.

    1. Investigation of Regional Mechanisms Responsible for Poor Oral Absorption in Humans of a Modified Release Preparation of the α-Adrenoreceptor Antagonist, 4-Amino-6,7-dimethoxy-2-(5-methanesulfonamido-1,2,3,4 tetrahydroisoquinol-2-yl)-5-(2-pyridyl)quinazoline (UK-338,003): The Rational Use of ex Vivo Intestine to Predict in Vivo Absorption
      A. Collett, R. H. Stephens, M. D. Harwood, M. Humphrey, L. Dallman, J. Bennett, J. Davis, G. L. Carlson and G. Warhurst
      Drug Metabolism and Disposition January 2008, 36 (1) 87-94; DOI: https://doi.org/10.1124/dmd.107.016865

  13. Stockis, Armel

    1. Pharmacokinetics and Metabolism of 14C-Brivaracetam, a Novel SV2A Ligand, in Healthy Subjects
      Maria Laura Sargentini-Maier, Pascal Espié, Alain Coquette and Armel Stockis
      Drug Metabolism and Disposition January 2008, 36 (1) 36-45; DOI: https://doi.org/10.1124/dmd.107.017129

  14. Strom, Stephen

    1. Novel Single Nucleotide Polymorphisms in the Promoter and Intron 1 of Human Pregnane X Receptor/NR1I2 and Their Association with CYP3A4 Expression
      Jatinder Lamba, Vishal Lamba, Stephen Strom, Raman Venkataramanan and Erin Schuetz
      Drug Metabolism and Disposition January 2008, 36 (1) 169-181; DOI: https://doi.org/10.1124/dmd.107.016600

  15. Suenaga, Ayaka

    1. Subdomain IIIA of Dog Albumin Contains a Binding Site Similar to Site II of Human Albumin
      Ken-ichi Kaneko, Hikaru Fukuda, Victor Tuan Giam Chuang, Keishi Yamasaki, Kohichi Kawahara, Hitoshi Nakayama, Ayaka Suenaga, Toru Maruyama and Masaki Otagiri
      Drug Metabolism and Disposition January 2008, 36 (1) 81-86; DOI: https://doi.org/10.1124/dmd.107.016873

  16. Sun, Huadong

    1. Permeability, Transport, and Metabolism of Solutes in Caco-2 Cell Monolayers: A Theoretical Study
      Huadong Sun and K. Sandy Pang
      Drug Metabolism and Disposition January 2008, 36 (1) 102-123; DOI: https://doi.org/10.1124/dmd.107.015321

  17. Suzuki, Hiroshi

    1. Hepatic UDP-Glucuronosyltransferases Responsible for Glucuronidation of Thyroxine in Humans
      Yoshihisa Kato, Shin-ichi Ikushiro, Yoshikazu Emi, Sekihiro Tamaki, Hiroshi Suzuki, Toshiyuki Sakaki, Shizuo Yamada and Masakuni Degawa
      Drug Metabolism and Disposition January 2008, 36 (1) 51-55; DOI: https://doi.org/10.1124/dmd.107.018184

T

  1. Tamai, Ikumi

    1. Oseltamivir (Tamiflu) Efflux Transport at the Blood-Brain Barrier via P-Glycoprotein
      Kaori Morimoto, Masanori Nakakariya, Yoshiyuki Shirasaka, Chihaya Kakinuma, Takuya Fujita, Ikumi Tamai and Takuo Ogihara
      Drug Metabolism and Disposition January 2008, 36 (1) 6-9; DOI: https://doi.org/10.1124/dmd.107.017699

  2. Tamaki, Sekihiro

    1. Hepatic UDP-Glucuronosyltransferases Responsible for Glucuronidation of Thyroxine in Humans
      Yoshihisa Kato, Shin-ichi Ikushiro, Yoshikazu Emi, Sekihiro Tamaki, Hiroshi Suzuki, Toshiyuki Sakaki, Shizuo Yamada and Masakuni Degawa
      Drug Metabolism and Disposition January 2008, 36 (1) 51-55; DOI: https://doi.org/10.1124/dmd.107.018184

  3. Theobald, Denis S.

    1. Identification of Cytochrome P450 Enzymes Involved in the Metabolism of the New Designer Drug 4′-Methyl-α-pyrrolidinobutyrophenone
      Frank T. Peters, Markus R. Meyer, Denis S. Theobald and Hans H. Maurer
      Drug Metabolism and Disposition January 2008, 36 (1) 163-168; DOI: https://doi.org/10.1124/dmd.107.017293

  4. Thummel, Kenneth E.

    1. The Influence of CYP3A5 Expression on the Extent of Hepatic CYP3A Inhibition Is Substrate-Dependent: An in Vitro-in Vivo Evaluation
      Nina Isoherranen, Shana R. Ludington, Raymond C. Givens, Jatinder K. Lamba, Susan N. Pusek, E. Claire Dees, David K. Blough, Kazunori Iwanaga, Roy L. Hawke, Erin G. Schuetz, Paul B. Watkins, Kenneth E. Thummel and Mary F. Paine
      Drug Metabolism and Disposition January 2008, 36 (1) 146-154; DOI: https://doi.org/10.1124/dmd.107.018382

  5. Tian, Xianbin

    1. Multidrug Resistance-Associated Protein 2 Is Primarily Responsible for the Biliary Excretion of Fexofenadine in Mice
      Xianbin Tian, Maciej J. Zamek-Gliszczynski, Jun Li, Arlene S. Bridges, Ken-ichi Nezasa, Nita J. Patel, Thomas J. Raub and Kim L. R. Brouwer
      Drug Metabolism and Disposition January 2008, 36 (1) 61-64; DOI: https://doi.org/10.1124/dmd.107.017319

  6. Tornio, Aleksi

    1. Trimethoprim and the CYP2C8*3 Allele Have Opposite Effects on the Pharmacokinetics of Pioglitazone
      Aleksi Tornio, Mikko Niemi, Pertti J. Neuvonen and Janne T. Backman
      Drug Metabolism and Disposition January 2008, 36 (1) 73-80; DOI: https://doi.org/10.1124/dmd.107.018010

V

  1. Vallejo, Jesus

    1. Regulation of Hepatic Drug-Metabolizing Enzyme Genes by Toll-Like Receptor 4 Signaling Is Independent of Toll-Interleukin 1 Receptor Domain-Containing Adaptor Protein
      Romi Ghose, Damara White, Tao Guo, Jesus Vallejo and Saul J. Karpen
      Drug Metabolism and Disposition January 2008, 36 (1) 95-101; DOI: https://doi.org/10.1124/dmd.107.018051

  2. Venkataramanan, Raman

    1. Novel Single Nucleotide Polymorphisms in the Promoter and Intron 1 of Human Pregnane X Receptor/NR1I2 and Their Association with CYP3A4 Expression
      Jatinder Lamba, Vishal Lamba, Stephen Strom, Raman Venkataramanan and Erin Schuetz
      Drug Metabolism and Disposition January 2008, 36 (1) 169-181; DOI: https://doi.org/10.1124/dmd.107.016600

  3. Visvikis-Siest, Sophie

    1. Transcription Factor and Drug-Metabolizing Enzyme Gene Expression in Lymphocytes from Healthy Human Subjects
      Gérard Siest, Elise Jeannesson, Jean-Brice Marteau, Anastasia Samara, Bérangère Marie, Michèle Pfister and Sophie Visvikis-Siest
      Drug Metabolism and Disposition January 2008, 36 (1) 182-189; DOI: https://doi.org/10.1124/dmd.107.017228

W

  1. Warhurst, G.

    1. Investigation of Regional Mechanisms Responsible for Poor Oral Absorption in Humans of a Modified Release Preparation of the α-Adrenoreceptor Antagonist, 4-Amino-6,7-dimethoxy-2-(5-methanesulfonamido-1,2,3,4 tetrahydroisoquinol-2-yl)-5-(2-pyridyl)quinazoline (UK-338,003): The Rational Use of ex Vivo Intestine to Predict in Vivo Absorption
      A. Collett, R. H. Stephens, M. D. Harwood, M. Humphrey, L. Dallman, J. Bennett, J. Davis, G. L. Carlson and G. Warhurst
      Drug Metabolism and Disposition January 2008, 36 (1) 87-94; DOI: https://doi.org/10.1124/dmd.107.016865

  2. Watkins, Paul B.

    1. The Influence of CYP3A5 Expression on the Extent of Hepatic CYP3A Inhibition Is Substrate-Dependent: An in Vitro-in Vivo Evaluation
      Nina Isoherranen, Shana R. Ludington, Raymond C. Givens, Jatinder K. Lamba, Susan N. Pusek, E. Claire Dees, David K. Blough, Kazunori Iwanaga, Roy L. Hawke, Erin G. Schuetz, Paul B. Watkins, Kenneth E. Thummel and Mary F. Paine
      Drug Metabolism and Disposition January 2008, 36 (1) 146-154; DOI: https://doi.org/10.1124/dmd.107.018382

  3. Weinshilboum, Richard M.

    1. Effect of Resveratrol on 17β-Estradiol Sulfation by Human Hepatic and Jejunal S9 and Recombinant Sulfotransferase 1E1
      Anna M. Furimsky, Carol E. Green, Lewanne E. Hunt Sharp, Paul Catz, Araba A. Adjei, Toufan Parman, Izet M. Kapetanovic, Richard M. Weinshilboum and Lalitha V. Iyer
      Drug Metabolism and Disposition January 2008, 36 (1) 129-136; DOI: https://doi.org/10.1124/dmd.107.016725

  4. Wen, Zhiming

    1. Pharmacokinetics and Metabolic Profile of Free, Conjugated, and Total Silymarin Flavonolignans in Human Plasma after Oral Administration of Milk Thistle Extract
      Zhiming Wen, Todd E. Dumas, Sarah J. Schrieber, Roy L. Hawke, Michael W. Fried and Philip C. Smith
      Drug Metabolism and Disposition January 2008, 36 (1) 65-72; DOI: https://doi.org/10.1124/dmd.107.017566

  5. Westley, Ian S.

    1. Glucuronidation of Mycophenolic Acid by Wistar and Mrp2-Deficient TR- Rat Liver Microsomes
      Ian S. Westley, Raymond G. Morris, Allan M. Evans and Benedetta C. Sallustio
      Drug Metabolism and Disposition January 2008, 36 (1) 46-50; DOI: https://doi.org/10.1124/dmd.107.017210

  6. Whigan, Daisy B.

    1. Disposition and Metabolism of [14C]Brasofensine in Rats, Monkeys, and Humans
      Mingshe Zhu, Daisy B. Whigan, Shu Y. Chang and Randy C. Dockens
      Drug Metabolism and Disposition January 2008, 36 (1) 24-35; DOI: https://doi.org/10.1124/dmd.107.016139

  7. White, Damara

    1. Regulation of Hepatic Drug-Metabolizing Enzyme Genes by Toll-Like Receptor 4 Signaling Is Independent of Toll-Interleukin 1 Receptor Domain-Containing Adaptor Protein
      Romi Ghose, Damara White, Tao Guo, Jesus Vallejo and Saul J. Karpen
      Drug Metabolism and Disposition January 2008, 36 (1) 95-101; DOI: https://doi.org/10.1124/dmd.107.018051

  8. Williamson, Gary

    1. Transport and Metabolism of Ferulic Acid through the Colonic Epithelium
      Laure Poquet, Michael N. Clifford and Gary Williamson
      Drug Metabolism and Disposition January 2008, 36 (1) 190-197; DOI: https://doi.org/10.1124/dmd.107.017558

  9. Wood, Jeffrey D.

    1. Regulation of CYP2A6 Protein Expression by Skatole, Indole, and Testicular Steroids in Primary Cultured Pig Hepatocytes
      Gang Chen, Rebecca-Ayme Cue, Kerstin Lundstrom, Jeffrey D. Wood and Olena Doran
      Drug Metabolism and Disposition January 2008, 36 (1) 56-60; DOI: https://doi.org/10.1124/dmd.107.017285

Y

  1. Yamada, Shizuo

    1. Hepatic UDP-Glucuronosyltransferases Responsible for Glucuronidation of Thyroxine in Humans
      Yoshihisa Kato, Shin-ichi Ikushiro, Yoshikazu Emi, Sekihiro Tamaki, Hiroshi Suzuki, Toshiyuki Sakaki, Shizuo Yamada and Masakuni Degawa
      Drug Metabolism and Disposition January 2008, 36 (1) 51-55; DOI: https://doi.org/10.1124/dmd.107.018184

  2. Yamasaki, Keishi

    1. Subdomain IIIA of Dog Albumin Contains a Binding Site Similar to Site II of Human Albumin
      Ken-ichi Kaneko, Hikaru Fukuda, Victor Tuan Giam Chuang, Keishi Yamasaki, Kohichi Kawahara, Hitoshi Nakayama, Ayaka Suenaga, Toru Maruyama and Masaki Otagiri
      Drug Metabolism and Disposition January 2008, 36 (1) 81-86; DOI: https://doi.org/10.1124/dmd.107.016873

  3. Yost, Garold S.

    1. Mechanism-Based Inactivation of Lung-Selective Cytochrome P450 CYP2F Enzymes
      Jaya S. Kartha and Garold S. Yost
      Drug Metabolism and Disposition January 2008, 36 (1) 155-162; DOI: https://doi.org/10.1124/dmd.107.017897

Z

  1. Zamek-Gliszczynski, Maciej J.

    1. Multidrug Resistance-Associated Protein 2 Is Primarily Responsible for the Biliary Excretion of Fexofenadine in Mice
      Xianbin Tian, Maciej J. Zamek-Gliszczynski, Jun Li, Arlene S. Bridges, Ken-ichi Nezasa, Nita J. Patel, Thomas J. Raub and Kim L. R. Brouwer
      Drug Metabolism and Disposition January 2008, 36 (1) 61-64; DOI: https://doi.org/10.1124/dmd.107.017319

  2. Zhu, Mingshe

    1. Disposition and Metabolism of [14C]Brasofensine in Rats, Monkeys, and Humans
      Mingshe Zhu, Daisy B. Whigan, Shu Y. Chang and Randy C. Dockens
      Drug Metabolism and Disposition January 2008, 36 (1) 24-35; DOI: https://doi.org/10.1124/dmd.107.016139
Back to top

In this issue